Similar articles

• Diphosphonates in the evaluation of metabolic bone disease.

  Fogelman I, Smith ML. Fogelman I, et al. Clin Rheumatol. 1982 Mar;1(1):41-4. doi: 10.1007/BF02032475. Clin Rheumatol. 1982. PMID: 6236012
• [Bone scintigraphy with 99Tcm polyphosphate in uremic osteodystrophy].

  Meneghello A, Bertoli M, Naso A, Casara D, Camposampiero A, Presacco D. Meneghello A, et al. Radiol Med. 1980 Oct;66(10):760-1. Radiol Med. 1980. PMID: 6452654 Italian. No abstract available.
• [Classification of bone scintigrams in hemodialysis patients].

  Ishibashi K, Miyamae T. Ishibashi K, et al. Kaku Igaku. 1985 Mar;22(3):367-76. Kaku Igaku. 1985. PMID: 3160875 Japanese. No abstract available.
• Optimizing the performance and interpretation of bone scans.

  Muroff LR. Muroff LR. Clin Nucl Med. 1981 Oct;6(10S):P68-76. doi: 10.1097/00003072-198110001-00012. Clin Nucl Med. 1981. PMID: 6271444 Review. No abstract available.
• [Radiological manifestations of uremic osteodystrophy].

  Meneghello A, Bertoli M, Naso A, Gasparotto ML, Presacco D, Poli I, Rebeschini M, Favaro P, Camposampiero A, Ruffatti AM, Romagnoli GF. Meneghello A, et al. G Clin Med. 1980 Feb;61(2):98-118. G Clin Med. 1980. PMID: 6778753 Review. Italian. No abstract available.